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Abstract
Background:  Cadherins are cell surface adhesion molecules that play important roles in
development of vertebrate tissues and organs. We studied cadherin2 expression in developing
zebrafish heart using in situ hybridization and immunocytochemical methods, and we found that
cadherin2 was strongly expressed by the myocardium of the embryonic zebrafish. To gain insight
into cadherin2 role in the formation and function of the heart, we analyzed cardiac differentiation
and performance in a cadherin2 mutant, glass onion (glo).
Results: We found that the cadherin2 mutant had enlarged pericardial cavity, disorganized atrium
and ventricle, and reduced expression of a ventricular specific marker vmhc. Individual
myocardiocytes in the glo mutant embryos became round shaped and loosely aggregated. In vivo
measurements of cardiac performance revealed that the mutant heart had significantly reduced
heart rate, stroke volume and cardiac output compared to control embryos. Formation of the
embryonic vascular system in the glo mutants was also affected.
Conclusion: Our results suggest that cadherin2 plays an essential role in zebrafish cardiovascular
development. Although the exact mechanisms remain unknown as to the formation of the enlarged
pericardium and reduced peripheral blood flow, it is clear that  myocardiocyte differentiation and
physiological cardiovascular  performance is impaired when cadherin2 function is disrupted.
Background
Zebrafish (Danio rerio) has emerged as an important
model system in the study of vertebrate development due
to its external development, transparency of embryos, and
its demonstrated utility as a genetic model. The process of
heart formation occurs in a similar way in all vertebrates
[1]. Heart development in the zebrafish is also rapid,
which allows for numerous short-term studies. The prim-
itive heart tube is formed by 22 hours post-fertilization
(hpf). The heart is beating and the circulation becomes
evident at 24 hpf. By 30 hpf, the heart tube starts to loop
to the right side of the embryo. By 36 hpf, chamber
boundaries are evident, although molecular markers can
distinguish them in the primitive heart tube [2,3]. Loop-
ing places both the atrium and the ventricle toward the
left of the embryo, however the atrium is further to the left
than the ventricle. By 60 hpf, the valves are present and by
the fifth day, the heart has assumed its adult configura-
tion, with the atrium sitting dorsally with respect to the
ventricle [1,4].
The fundamental plan of the vascular system as it devel-
ops in the zebrafish is similar to that of other vertebrates.
The overall form of the zebrafish vasculature is estab-
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lished early, before the initiation of circulation, and the
pattern of major vessel tracts is reproducible from embryo
to embryo [5]. Circulation begins at approximately 24–26
hpf and initially flows through a simple single circulatory
loop. Cells from the dorsal margin of the lateral plate
migrate medially to form the intermediate cell mass [6].
This mass gives rise to both the endothelia and the major
trunk vessels and the first cohort of blood cells [7]. How-
ever, many early vasculogenic vessels first appear as a net-
work or plexus of smaller vessels, with little apparent
pattern or differentiated identity [8,9]. By 2.5–3 days post-
fertilization (dpf), the trunk and tail intersegmental ves-
sels are fully formed and by 6 dpf, the overall basic pattern
of the vaculature is in place [10].
Although vertebrate cardiovascular development has been
well described morphologically, the molecular and phys-
iological mechanisms underlying these events are only
beginning to be understood. Results from gene expression
pattern and/or functional studies suggest that a variety of
molecules, including transcription factors (e.g. Gata4,
Nkx2.5), morphogenetic regulators (e.g. Hand2, Pitx2,
Xin), endothelial growth factors (e.g. VEGF-A), cardiac
specific proteins (e.g. cmlc1, cmlc2, and vmhc), cell adhe-
sion molecule (e.g. cadherin2 and cadherin5, see below),
are involved in the cardiac patterning and morphogenesis
of the vertebrate heart [3,11-20].
The cadherins are a family of Ca++-dependent transmem-
brane molecules that mediate cell adhesion mainly
through homophilic interactions [21-23]. Cadherin2, the
first cadherin discovered in the vertebrate nervous system
[24], has been shown to be of critical importance in the
early differentiation of the vertebrate central and periph-
eral nervous structures [18,25-30]. Unlike the wide
expression of cadherin2, expression of cadherin5 (also
called VE-cadherin), is confined to the endothelial cells of
both developing and adult vasculature [20,31,32].
Despite the importance of cardiovascular tissue itself and
cadherin molecules in animal development, there are
only a few published reports on cadherins function in ver-
tebrate cardiovascular development. Zebrafish with muta-
tions in cadherin2 (parachute, or pac mutant, [28]; glass
onion, or glo mutant, [29]) have recently been identified,
and their phenotypes studied. However, most of the anal-
ysis was concentrated on the central nervous system. So
far, detailed information on the developmental profile of
cadherin2 expression in the vertebrate cardiac tissue has
been performed on only the chick and mice. Moreover,
functional analysis was limited almost exclusively to
descriptions of anatomical defects in the heart of embryos
whose cadherin2 function was blocked [18,33]. We pro-
pose to study cardiac differentiation, cardiac performance
and formation of the vascular system in the glo mutant in
order to elucidate the role(s) of cadherin2 plays in the for-
mation and function of the cardiovascular system.
Results
Cadherin2 expression in developing zebrafish heart
Cadherin2 expression in the developing zebrafish heart
was studied using whole mount in situ hybridization and
immunocytochemical methods on tissue sections. Strong
cadherin2  message was detected in the developing
zebrafish heart of all stages examined (24 hpf to 80 hpf;
Fig. 1). Expression levels were higher in the bulbus arteri-
osus and the ventricle than in the atrium in whole mount
hearts (Fig. 1D and 1E). Examination of sections from the
whole mount hearts and tissue sections processed for
cadherin2 immunostaining showed that the labeling was
confined mainly to the myocardial layer at the stages
examined (Fig. 1G). This was confirmed by double labe-
ling experiments using the cadherin2 antibody and an
anti-mouse monoclonal antibody Zn-5, which has been
shown to recognize differentiating zebfrafish ventricular
myocardium (Deborah Yelon, New York University, per-
sonal communication; Fig. 1H–J). The difference in
cadherin2 staining between the atrium and ventricle was
mainly due to the thickness of these structures with the
ventricle having a myocardium consisting 2–3 cell layers
while the atrium myocardium having a single cell layer
(Fig. 1F; [4]).
Analysis of cardiac performance in glo mutant embryos
The expression pattern of cadherin2 in the embryonic
zebrafish heart suggests that this adhesion molecule is
involved in the development of normal zebrafish cardiac
function. We tested this idea by examining several key car-
diac performance parameters: heart rate, stroke volume,
cardiac output, and contraction time in control and glo
mutant 30–72 hpf embryos (Fig. 2). By 30 hpf, these
parameters can be readily recorded under an inverted dis-
section microscope. Mean heart rates of glo  mutant
embryos were lower than controls at this stage, but the dif-
ference was not statistically significant (Fig. 2A). The heart
rates increased by almost 60% in both groups over the 42-
hour measurement period. However, the trajectory of this
increase was significantly different between the control
and glo mutant embryos. Between 30–48 hpf, differences
between the mean heart rates of these two groups grew
more prominent, with the values significantly lower in the
glo mutant embryos than the controls at 36 and 48 hpf
(Fig. 2A). Interestingly, differences in the heart rates
between the two groups became smaller between 48–72
hpf, due to a faster increase in the glo mutant heart rates.
Although the mean heart rates were still significantly
lower for glo mutant embryos at 58 hpf, their values were
similar to the controls at 72 hpf. Moreover, variations in
hearts rate were also significantly higher in the glo mutant
embryos.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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Mean stroke volume in control and glo mutant hearts was
similar at 30 hpf, and it became larger in both groups as
development proceeded (Fig. 2B). In control embryos,
stroke volume increased more rapidly during develop-
ment with the difference showing statistical significance at
72 hpf. This late significance was due, at least partially, to
large variations of the stroke volume in both groups. Mul-
tiplying stroke volume by heart rate produces cardiac out-
put (Fig. 2C). Mean cardiac output increased in both
groups during the 42-hour measurement period with the
slope of the increase significantly higher in the control
group. As with stroke volume, cardiac output was similar
between the two groups at 30 hpf, and the control
embryos had higher cardiac output than the glo mutant
embryos at the remaining recording time points, although
their values were not significantly different until 72 hpf.
Again, cardiac output variability was high in both groups.
For the majority of the developmental window investi-
gated, the contraction time (time from diastole to systole)
for glo mutant hearts was slower than controls (Fig. 2D).
This difference was statistically significant during the first
two measurement times (30 and 36 hpf), but by 72 hpf,
the contraction time became similar between the glo and
Cadherin2 expression in developing zebrafish heart Figure 1
Cadherin2 expression in developing zebrafish heart. Anterior is to the left and dorsal is up for panels A-H. Panels A-C 
are lateral views of the head region of whole mount zebrafish embryos labeled by in situ hybridization with cadherin-2 cRNA. 
The arrow points to the heart. Panels D and E are lateral views of higher magnifications of the heart. Panel F is a parasagittal 
section of a heart processed for whole mount in situ hybridization. Panels G and H are parasagittal sections of the ventricle 
processed for cadherin-2 (Cdh2) and Zn-5 immunocytochemical staining, respectively, both showing that the staining is con-
fined mainly to cell membranes of myocardiocytes. Panels I and J show the same cross section of the ventricle (dorsal up) dou-
ble-labeled with cadherin-2 antibody (panel I) and Zn-5 antibody (panel J). The arrows and arrowheads point to the same cells 
respectively. Abbreviations: a, atrium; ba, bulbus arteriosus; c, cerebellum; di, diencephalon; ec, endothelium; h, hindbrain; mc, 
myocardium; ot, optic tectum; v, ventricle.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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control hearts. Moreover, the variation in contraction
times was also significantly higher in the glo  mutant
hearts, reflecting the irregular nature of cardiac contrac-
tions in this group.
Gross morphological defects in the heart of the glo mutant 
and cadherin2 morphants
The decreased cardiac function in the glo mutant embryos
was likely caused by morphological changes in the mutant
heart. The pericardial cavity was greatly enlarged in all glo
mutants (Fig. 3C and 3D), in most (264/305, 86.6%) of
cadherin2  morphants (Fig. 3B), but in only a small
number (3/78, 3.4%) of embryos injected with a standard
control morpholino oligonucleotide. glo mutant embryos
become readily distinguishable from their heterozygous
and wild type cohorts at 24 hpf by having tail blisters or
clubbed tails [29]. At this stage the pericardial cavity of the
glo  mutant embryos was similar in size to control
embryos. The glo mutant pericardial cavity remained sim-
ilar in size to control embryos at 28 and 36 hpf (data not
shown), but by 50 hpf, the glo mutant pericardial cavity
had become greatly enlarged compared to the control
embryos (Figs. 3A and 3D, 4A and 4B).
In control 48–50 hpf embryos, the linear cardiac tube, ori-
ented rostrocaudally in younger stages, has developed
into the atrium and ventricle, separated by the atrioven-
tricular constriction, with the former located ventrally and
to the left of the latter [3,4]. Both the atrium and ventricle
are either tubular or oval shaped with smooth surfaces.
Gross cardiac morphological defects varied in the glo
mutant embryos, with some showing tubular, often
smaller, atrium and ventricle (Fig. 4B), while others
exhibiting irregular shaped atrium and/or ventricle, often
Measurements of cardiac performance in control and glo mutant embryos Figure 2
Measurements of cardiac performance in control and glo mutant embryos. Panel A shows mean heart rate in both 
groups during development and panel B shows stroke volume in the same larvae. Panel C is the result of the product of the 
data in panels A and B. Panel D shows the time from end diastole to end systole. Asterisks represent a significant difference 
between the control and the glo embryos during that time of development. All data shown are means ± S.E.M.
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with uneven surfaces (Fig. 4C). Moreover, the looping of
the heart evident in the control (Fig. 5C) was mostly miss-
ing in the mutant heart (Fig. 5D). Some gross cardiac mor-
phological changes were easily detectable at 36 hpf (Fig.
4E). Similar gross cardiac defects were obvious in about
half of the cadherin2  morphants examined (data not
shown), but often with less severity than the glo mutants,
and no obvious gross cardiac defects were seen in embryos
injected with the standard control morpholino oligonu-
cleotide (data not shown) or in the pac  mutants as
reported by [28].
Differentiation of the glo mutant heart is affected
Cardiac differentiation of the glo mutants and cadherin2
morphants was analyzed using cardiac specific markers
nkx2.5, cmlc2, vmhc [34], cdh5 [20] or Zn-5 immunostain-
ing. Nkx2.5 is a transcription factor crucial for vertebrate
cardiac development [17], and it is expressed mainly by
the ventricle at 48–52 hpf (Fig. 5A). Its mRNA expression
in the glo mutant heart appeared to be similar to the con-
trol heart (Fig. 5A and 5B). cmlc2  labels the cardiac
myosin light chain 2 present in both the embryonic
zebrafish atrium and ventricle ([34]; Fig. 5C). Similar to
cmlc2 expression in the control heart, cmlc2 was expressed
by both the atrium and ventricle of the glo mutant heart
Enlarged pericardial cavity in glo mutant Figure 3
Enlarged pericardial cavity in glo mutant. Compared to a control embryo (panel A), the pericardial cavity (pc) is much 
enlarged in a cadherin2 morphant (panel B) and a glo mutant embryo (panels C and D). All panels are images from live embryos 
showing lateral views (anterior to the left and dorsal up) of the pericardial cavity and heart. Panel D is a higher magnification of 
the pericardial cavity showing in panel C.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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(Fig. 5C and 5D). Zebrafish vmhc stands for the ventricular
myosin heavy chain gene, and it labels the ventricular
myocardium and skeletal muscles of the body ([34]; Fig.
5E). vmhc expression was moderately or greatly reduced in
the glo mutant heart, while its expression in their trunk
muscle appeared to be less affected (Fig. 5F). cdh5  is
expressed by zebrafish endothelial layer of the heart
throughout embryonic development, with stronger
expression in the ventricle than the atrium in two-day old
embryos ([20]; Fig. 5G). Expression of cdh5  in the glo
mutant heart was similar to the control (Fig. 5H).
In the control ventricle, Zn-5 immunostaining was con-
centrated on the cell membrane of the myocardiocytes
(Figs. 1H and 1J, 6E). The ventricular myocardiocytes in
control embryos at 48–52 hpf were elongated, fusiform
shaped, and form tight associations with one another
(Fig. 6A and 6E). Zn-5 labeling of the myocardiocytes in
embryos injected with the standard control morpholino
oligonucleotide was indistinguishable from that in wild
type control embryos (data not shown). Similar to the
control heart, Zn-5 immunoreactivity in the glo and pac
mutants and cadherin2  morphant hearts was confined
mainly to the ventricle (Figs. 4B, 6B–D), but the staining
within the mutant and morphant heart ventricles was
greatly altered. Zn-5 labeling was detected both on the cell
membrane and in the cytoplasm of many glo  and  pac
mutants, and in cadherin2 morphant myocardiocytes (Fig.
6B–D). These cells were often roundly shaped, scattered
or formed clusters. These changes were also detected in
younger glo mutant embryos (Fig. 4E).
Formation of the vascular system in glo mutants is affected
The enlarged pericardial cavity in cadherin2  morphants
and glo mutant embryos may be caused by a poorly devel-
oped vascular system in these animals, resulting in an
accumulation of fluid in the pericardial cavity. We exam-
ined vasculature formation in the glo  mutant embryos
using the endothelial marker cdh5  (Fig. 7). Although
some of the major blood vessels were present at 28 hpf in
the mutants, their staining was greatly reduced compared
to control embryos (Fig. 7G). Intersegmental vessels in
the body and tail are well-developed in control embryos
at this stage ([20]; Fig. 7E), but poorly formed in the glo
mutants (Fig. 7F). By 50 hpf, an elaborate vascular system
can be detected using the cdh5 staining in zebrafish ([20];
Fig. 8). The majority of the blood vessels seen in control
embryos, including the lateral dorsal aorta, dorsal aorta,
posterior cardinal vein, hyoid and branchial arch vessels,
could also be found in the glo mutant embryos (Fig. 8B).
Gross cardiac morphological defects in glo mutant embryos revealed by Zn-5 immunostaining Figure 4
Gross cardiac morphological defects in glo mutant embryos revealed by Zn-5 immunostaining. All panels show 
lateral views of the heart of whole mount embryos labeled with the Zn-5 antibody. Anterior is to the left and dorsal is up. 
Abbreviations are the same as in Figure 1.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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Expression of cardiac specific genes in control (left column) and glo mutant hearts (right column) Figure 5
Expression of cardiac specific genes in control (left column) and glo mutant hearts (right column). Panels A-D, G 
and H are ventral views of whole mount hearts with dorsal up. Panels E and F are lateral views of whole mount hearts with 
anterior to the left and dorsal up. Abbreviation: tm, trunk muscles. Other abbreviations are the same as in Figure 1.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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The intersegmental vessels in the mutant embryos were
poorly stained and disorganized compared to those in
control embryos (Fig. 8C and 8D). Injection of FITC-Dex-
tran into anesthetized control embryos resulted in a vas-
culature labeling pattern similar to cdh5 staining in the
control embryos (Fig. 8A, 8C, 8E and 8G), but there was
very little FITC-Dextran labeling in glo mutant embryos
(Fig. 8F and 8H).
Discussion
In this study, we show that zebrafish cadherin2 is
expressed by the myocardium of both the atrium and ven-
tricle during critical periods of zebrafish cardiac develop-
ment, and that loss of cadherin2 function disrupts
differentiation of myocardiocytes, normal functioning of
the zebrafish heart and formation of the intersegmental
vasculature. There are only a few systems (e.g. visual and
cardiac systems) and organisms in which one can readily
perform in vivo studies of gene function in cell and tissue
differentiation together with measurement of organ phys-
iological performance affected by the loss of the gene
function. This study further demonstrates the usefulness
of zebrafish as a model organism to study gene function
in vertebrate cardiac differentiation and function. The
reduced cardiac performance in the glo mutant embryos
likely results from altered atrial and ventricular morphol-
ogy, which in turn is likely caused by the changes in the
myocardiocyte differentiation.
Pericardial and cardiac gross morphology is greatly altered 
in cadherin2 morphants and glo mutant embryos
Our finding that the pericardial cavity was greatly
enlarged in the vast majority of the cadherin2 morphants
and in all glo mutants suggests that cadherin2 function
could be required for developing a normal pericardial cav-
ity. However, it cannot be ruled out that altered kidney
function could be causing pericardial enlargement via
fluid accumulation. Thus, the actual cause(s) for the for-
mation of such an enlarged pericardial cavity, likely due to
an accumulation of fluid in the cavity, in these embryos is
unclear. It may have more to do with the much-weakened
cardiac function in the mutant embryos than the develop-
Zn-5 immunostaining reveals myocardiocyte defectsin a cadherin2 morphant, a pac mutant embryo and glo mutant embryos Figure 6
Zn-5 immunostaining reveals myocardiocyte defectsin a cadherin2 morphant, a pac mutant embryo and glo 
mutant embryos. Zn-5 immunostaining reveals myocardiocyte defects in a cadherin2 morphant (panel C), a pac mutant 
embryo (panel D) and glo mutant embryos (panels B, F and G). All embryos, except panel G (4-day old) are 48–50 hpf. Panels 
A-D are lateral views of whole mount hearts with anterior to the left and dorsal up. Panels E-G are sections of zebrafish hearts 
processed for whole mount Zn-5 immunostaining. The asterisk in panel B indicates a large cluster of myocardiocytes with Zn-
5 immunoreactivity detected in both their cell membranes and cytoplasm. Arrows in panels C and D point to round shaped 
myocardiocytes with staining in the cell membrane and cytoplasm. Panel E is a parasagittal section (anterior to the left lower 
corner and dorsal to the left upper corner) of a control heart. Asterisks in this panel indicate regions that are out of focus. 
Panel F is a parasagittal section of a glo mutant heart (anterior to the left and dorsal up). Panel G is a parasagittal section (ante-
rior to the left and dorsal up) of 4-day old glo mutant heart. Arrows in panels F and G point to round shaped myocardiocytes 
with labeling in their cell membranes and cytoplasm, while the arrowhead in panel F indicates a myocardial cell with weak labe-
ling on its cell membrane.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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Development of the vasculature system in 28 hpfcontrol and glo mutant embryos as revealed by cdh5 staining Figure 7
Development of the vasculature system in 28 hpfcontrol and glo mutant embryos as revealed by cdh5 staining. 
Development of the vasculature system in 28 hpf control (panels on the left column and the embryo on the left in panel G) and 
glo mutant embryos (the remaining panels) as revealed by cdh5 staining. Panels A-F show lateral views of whole mount embryos 
(anterior to the left and dorsal up). Panels C and D are higher magnifications of the head region, while panels E and F are higher 
magnifications of the trunk and tail regions. Panel G shows dorsal views of the embryo with anterior to the top. Abbreviations: 
aa1, mandibular arch; cadi, caudal division of the internal carotid artery; ccv, common cardinal vein; da, dorsal aorta; lda, lateral 
dorsal aorta; mcev, middle cerebral vein; pcv, posterior cardinal vein; pmbc, primordial midbrain channel; se, intersegmental 
vessel.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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cdh5 staining and FITC-dextran labeling of the developing vasculature system in 50 hpf whole mount embryos Figure 8
cdh5 staining and FITC-dextran labeling of the developing vasculature system in 50 hpf whole mount embryos. 
(see Abbreviations) Panels A-D and E-H show cdh5 staining and FITC-dextran labeling, respectively, of the developing vascula-
ture system in 50 hpf whole mount embryos (anterior to the left and dorsal up for all panels). Panels in the left column are 
from control embryos, while panels in the right column are from glo mutant embryos. Panels A, B, E and F are lateral views of 
the head region, while the remaining panels (higher magnifications) show lateral views of the trunk and/or tail regions. The 
head, trunk and tail of the mutant embryos are outlined by the dashed lines.BMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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ment of the vascular system. This idea is supported by our
finding that most of the major blood vessels were present
in the glo mutant embryos, but there was little labeling of
the blood vessels using the FITC-Dextran injection (Fig.
8).
Enlarged pericardial cavity was reported in cadherin2
mutant mice [18], but not seen in the pac mutants [28].
This difference likely results from different degrees of
knockdown/knockout of cadherin2 function in these
mutants. It is possible that a small amount of functional
cadherin2 protein is produced in the pac mutants due to
alternative splicing [29], therefore defects in the pac
mutants are not as severe as in the glo mutants.
The gross morphological defects observed in the glo
mutant hearts are likely caused by changes in the mor-
phology of individual myocardiocytes. Although defects
in the myocardiocytes were observed in both glo and pac
mutant embryos, the gross cardiac morphological defects
were obvious only in the former. This again, is likely due
to differences in the degree of cadherin2 function disrup-
tion, with a complete loss of cadherin2 function in the glo
mutant embryos, while perhaps some cadherin2 function
remaining in the pac mutant embryos (see above). The
enlarged pericardial cavity is unlikely one of the major
causes of the atrial and ventricular disorganization,
because the gross morphological defects can be detected
at 36 hpf, when there is no obvious change in the size of
the pericardial cavity.
Cadherin2 plays an important role in myocardiocyte 
differentiation, cardiac morphogenesis and performance
During cardiac development, myocardiocytes express car-
diac specific markers such as nkx2.5,  cmlc2,  vmhc  and
cdh5[3,20]. Despite greatly altered gross cardiac morphol-
ogy and myocardiocytes morphology in glo  mutant
embryos, expression of nkx2.5, cmlc2 and cdh5 is largely
unchanged, suggesting that cadherin2 is not required for
normal expression of these genes. However, expression of
vmhc, a ventricle specific gene, in the glo mutant heart is
reduced compared to control embryos. Although vmhc
role in cardiac formation and function has not being stud-
ied in vertebrates, loss of function in an atrium specific
myosin heavy chain has been linked to disruption in atrial
function and altered ventricular morphogenesis in
zebrafish [35], suggesting that vmhc may play a similar
role in ventricular myocardiocyte differentiation and
function. Therefore, it is reasonable to speculate that
cadherin2 function in vertebrate cardiac development and
the function may be mediated, at least partially, by its
effect on vmhc expression.
Myocardiocytes undergo extensive morphological
changes during cardiac morphogenesis [36]. For example,
cuboidal shaped chicken myocardiocytes become flat-
tened and tightly associated when the heart begins to con-
tract, and the myocardiocytes become fusiform shaped
and arranged in the circumferential direction during loop-
ing [36], similar to the zebrafish myocardiocytes (Fig. 6A
and 6E). Many myocardiocytes in the glo mutant become
round shaped and lack tight association, which may have
contributed to poor electrical conduction between cells,
thus reducing the contraction rate shown in glo mutant
embryos. This also may have contributed to the gross car-
diac morphological defects including the disrupted heart
looping observed in both the cadherin2 mutant mice [18]
and glo mutant embryos.
The loss of cadherin2 function does not affect all aspects
of myocardiocyte differentiation because myocardiocytes
in the cadherin2 mutant mice and glo mutant embryos
still contract and/or express cardiac specific genes (see
above). Other cell adhesion molecules such as N-CAM
and other cadherin molecules may still function in these
animals. Although most of the blood vessels were present
as indicated by cdh5 labeling, it is unclear whether or not
these cdh5-positive vessels were normal. As was shown in
the heart, cdh5 staining in the glo mutants was similar to
controls. It is not surprising that the formation of the
major trunk vessels is not greatly affected in the glo mutant
embryos, since the zebrafish vasculature system express
cdh5, instead of cadherin2. It is possible that there are
defects on those blood vessels, but we have no other
markers (e.g. Zn-5, vmhc) to assess their integrity. Addi-
tionally, the intersegmental vessels and all other vessels
formed via angiogenic remodeling are poorly formed or
not present in glo mutant embryos. This is likely a proxi-
mal effect of the lack of pressure and flow generated by the
glo mutant embryo heart, and/or due to cadherin2 func-
tion on the trunk and tail muscle development [37].
Conclusion
Our results suggest that cadherin2 plays an essential role
in zebrafish cardiovascular development. Although the
exact mechanisms remain unknown as to the formation
of the enlarged pericardium and reduced peripheral blood
flow, it is clear that myocardiocyte  differentiation and
physiological performance is impaired.
Methods
Zebrafish
Zebrafish (Danio rerio) were maintained at 28.5°C as
described in the Zebrafish Book [38]. The glo  hetero-
zygous mutant carriers and their wildtype siblings from a
single breeding, obtained from the Zebrafish Interna-
tional Resource Center at the University of Oregon
(Eugene, OR) as embryos, were raised to reproductive
maturity in the animal care facility at the University of
Akron. Pair-wise breeding was performed to identify gloBMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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heterozygous mutant carriers, and the glo mutant embryos
were identified by gross morphological phenotype. Their
wildtype and heterozygous siblings were used as controls.
Embryos for cadherin2 morpholino oligonucleotides
(MO) experiments were obtained from breeding of
wildtype adult zebrafish. Zebrafish embryos homozygous
for the pac mutation (pactm101B) were obtained from Max-
Planck Institute for Developmental Biology (Tübingen,
Germany). Embryos for whole mount in situ hybridiza-
tion were raised in PTU (1-phenyl-2-thiourea, 0.003%) in
order to reduce optical interference of pigments. All ani-
mal-related procedures were approved by the Care and
Use of Animals in Research Committee at the University
of Akron.
Measurement of cardiac performance in control and glo 
mutant zebrafish embryos
glo mutant (N = 10) and control zebrafish embryos (het-
erozygous and wildtype siblings of the glo embryos, N = 8)
were used for measuring cardiac function. Mutant
embryos were identified and separated from wild type
embryos using a Leica dissecting microscope, based on
morphological differences such as curved spines and tail
blisters [29]. The embryos were dechorionated at approx-
imately 24 hpf and were kept in a small plastic compart-
mentalized container (2.5 ml for each compartment) with
tank water at 28.5°C for the duration of the experiment.
Immediately before each measurement, the embryos were
immobilized using MS-222 (0.02%). At this early stage of
development and at this low concentration of MS-222,
there are no measurable effects of this anesthesia on the
cardiovascular system (unpublished data). The embryos
were digitally recorded at 30 hpf, 36 hpf, 48 hpf, 58 hpf,
and 72 hpf using a temperature controlled inverted micro-
scope (Leica, DMIRB) equipped with a digital video cam-
era (Redlake MASD, San Diego, CA). For each embryo at
each selected period of development, a 10 sec digital
video was captured at 0.008 second intervals (125 frames
per second). At the completion of each video, the individ-
ual fish were returned to their respective compartments
and were tracked throughout the experiment.
Videos were analyzed for heart rate, end diastolic volume,
end systolic volume, stroke volume, and cardiac output
using ImagePro Plus® imaging software (Media Cybernet-
ics, Silver Spring, MD). Heart rate was calculated by count-
ing the number of sequential contractions, beginning and
ending at end diastole, occurring in the video file and
dividing by the exact time interval. End diastolic volume
was determined by measuring the perimeter of the ventri-
cle at diastole (obtained by tracing the ventricle in a single
frame of the cardiac cycle video stopped where the ventri-
cle was at its largest point) along with the length and
width of the ventricle at diastole. End systolic volume was
determined by measuring the perimeter of the ventricle at
systole (where the ventricle was at its narrowest width fol-
lowing diastole) in addition to the length and width of the
ventricle at systole. The resulting ventricular volumes were
calculated using the formula (8/3π) a/L, where a is the
area of the traced ventricle and L is the length of the ven-
tricle at either diastole or systole [39]. The stroke volume
was calculated by subtracting the end systolic volume
from the end diastolic volume and the cardiac output was
calculated by multiplying the stroke volume by the heart
rate. Data were analyzed for differences between the glo
and control embryos and over development time by using
a two-way repeated measure ANOVA. Post hoc compari-
sons were performed using Tukey's multiple comparisons
procedure. All physiological data presented are means ±
S.E.M.
MO and FITC-dextran Injections
A cadherin2 translation blocking morpholino oligonucle-
otide (5'-TCTGTATAAAGAAACCGATAGAGTT-3', [28], or
a standard control (5'-CCTCTTACCTCAGTTACAATT-
TATA-3'), gifts from Dr. James Marrs (Indiana University)
who purchased it from Gene Tools, Corvallis OR, was
microinjected into either blastomeres and/or the yolk
immediately below the blastomeres of 1–4 cell stage wild
type embryos. Injected embryos were allowed to develop
at 28.5° C until desired stages. Fluorescein isothiocyanate
(FITC)-dextran (Sigma) was injected into the common
cardinal vein of anesthetized embryos (56 hpf) according
to [40].
Tissue processing
Zebrafish embryos were euthanized in 0.02% methane
tricaine sulfonate (MS-222, Sigma, St Louis, MO) and
fixed in 4% paraformaldehyde in 0.1 M phosphate buff-
ered saline (PBS) overnight at 4°C. To prepare tissue for
whole mount in situ hybridization or immunohistochem-
istry, the tissue was rinsed in PBS, followed by 70% meth-
anol and 100% methanol. The tissue was stored in 100%
methanol at -20°C. Preparation of tissues for immunohis-
tochemical staining on sections was described previously
[41]. Briefly, the fixed tissue was processed through a
graded series of increasing sucrose concentrations, placed
in 20% sucrose in PBS overnight, then embedded and fro-
zen in a mixture of OCT embedding compound and 20%
sucrose (1:1, v/v). A cryostat was used to obtain 12–14 μm
sections. Some glo  and control embryos processed for
whole mount in situ hybridization or immunostaining
were embedded and sectioned as described above. Tissue
sections were collected on pretreated glass slides (Fisher
Scientific, Pittsburgh, PA), dried at room temperature and
stored at -80°C.
In situ hybridization
A cDNA containing the presequence, the extracellular and
transmembrane domains of zebrafish cadherin2, obtainedBMC Developmental Biology 2006, 6:23 http://www.biomedcentral.com/1471-213X/6/23
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by RT-PCR from 24 hpf embryonic zebrafish total RNA,
was used as a template to generate anti-sense and sense
cadherin2  cRNA probes [42]. cDNAs used to generate
zebrafish nkx2.5, cardiac myosin light chain 2 (cmlc2), and
ventricular myosin heavy chain (vmhc) cRNA probes were
kindly provided by Deborah Yelon at the New York Uni-
versity [34]. Zebrafish cdh5 cDNA used to generate cdh5
cRNA probes was kindly provided by Jon Larson at the
Discovery Genomics [20]. Synthesis of digoxigenin-
labeled cRNA probes, procedures for whole mount in situ
hybridization were described previously [41]. Anti-digox-
igenin Fab fragment antibodies conjugated to alkaline
phosphatase were used for immunocytochemical detec-
tion of the cRNA probes, and this was followed by an
NBT/BCIP color reaction step (Roche Molecular Biochem-
icals, Indianapolis, IN).
Immunohistochemistry
Procedures for whole mount immunohistochemistry and
immunostaining on tissue sections were described in
detail previously [43,44]. Primary antibodies used were
affinity purified zebrafish cadherin2 antibody (1:80, [43])
and Zn-5 (1:1000, Zebrafish International Resource
Center, University of Oregon, Eugene, OR). Biotinylated
secondary antibodies (Vector Laboratories, Burlingame,
CA) were used at 1:200. Visualization of the reaction was
achieved by using a DAB kit (Vector Laboratories). For
immunofluorescent double labeling experiments, the sec-
ondary antibodies were Cy3-conjugated anti-rabbit IgG
and FITC-conjugated anti-mouse IgG (Jackson Immu-
noResearch Laboratories, West Grove, PA) for the detec-
tion of cadherin-2 and Zn-5, respectively.
Abbreviations
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artery; h, heart; mta, metencephalic artery; ov, optic vein;
pa, pectoral artery; pcev, posterior cerebral vein; pra, pros-
encephalic artery; va, ventral aorta. Other abbreviations
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